Scholarly Index
Gérald Raverot
Hospices Civils de Lyon; 12,123 total citations; 406 total publications; best world rank #9
Hospices Civils de Lyon
12,123Total citations
406Total publications
58H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| Pituitary Gland Disorders and Treatments | Lifetime | 140 | FR 10 | 99.05 |
| Glioma Diagnosis and Treatment | Lifetime | 416 | FR 16 | 98.71 |
| Adrenal and Paraganglionic Tumors | Lifetime | 137 | FR 15 | 98.58 |
| Neuroendocrine Tumor Research Advances | Lifetime | 691 | FR 38 | 97.79 |
| Growth Hormone and Insulin-like Growth Factors | Lifetime | 568 | FR 28 | 97.51 |
| Meningioma and schwannoma management | Lifetime | 751 | FR 36 | 96.50 |
| Pituitary Gland Disorders and Treatments | 2021-2025 | 9 | FR 2 | 99.57 |
| Glioma Diagnosis and Treatment | 2021-2025 | 66 | FR 2 | 99.14 |
| Adrenal and Paraganglionic Tumors | 2021-2025 | 69 | FR 6 | 96.74 |
| Growth Hormone and Insulin-like Growth Factors | 2021-2025 | 54 | FR 5 | 96.54 |
| Neuroendocrine Tumor Research Advances | 2021-2025 | 233 | FR 12 | 94.92 |
| Meningioma and schwannoma management | 2021-2025 | 702 | FR 39 | 87.10 |
| Adrenal Hormones and Disorders | 2021-2025 | 350 | FR 16 | 81.49 |
| Mathematical Biology Tumor Growth | 2021-2025 | 784 | FR 41 | 54.41 |
| TGF-β signaling in diseases | 2021-2025 | 467 | FR 11 | 38.98 |